Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.

Saved in:
Bibliographic Details
Title: Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
Authors: Aronne LJ; Comprehensive Weight Control Center, Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, New York., Horn DB; University of Texas Center for Obesity Medicine and Metabolic Performance, Department of Surgery, University of Texas McGovern Medical School, Houston., le Roux CW; Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin.; Diabetes Research Centre, Ulster University, Coleraine, United Kingdom., Ho W; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles.; David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles., Falcon BL; Eli Lilly, Indianapolis., Gomez Valderas E; Eli Lilly, Indianapolis., Das S; Eli Lilly, Indianapolis., Lee CJ; Eli Lilly, Indianapolis., Glass LC; Eli Lilly, Indianapolis., Senyucel C; Eli Lilly, Indianapolis., Dunn JP; Eli Lilly, Indianapolis.
Corporate Authors: SURMOUNT-5 Trial Investigators
Source: The New England journal of medicine [N Engl J Med] 2025 Jul 03; Vol. 393 (1), pp. 26-36. Date of Electronic Publication: 2025 May 11.
Publication Type: Clinical Trial, Phase III; Comparative Study; Equivalence Trial; Journal Article; Multicenter Study
Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1533-4406
DOI:10.1056/NEJMoa2416394